Back to top
more

Glaukos (GKOS)

(Delayed Data from NYSE)

$121.62 USD

121.62
532,205

+1.16 (0.96%)

Updated Aug 9, 2024 04:00 PM ET

After-Market: $121.63 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

5 Stocks with Recent Price Strength to Boost Your Returns

by Zacks Equity Research

One should primarily target stocks that have recently been on a bullish run. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.

    Akers Biosciences (AKER) Closes Offering of 1.7M Shares

    by Zacks Equity Research

    Akers Biosciences, Inc. (AKER) recently announced the closing of a public offering of 1.7 million common shares.

      4 Profitable Stocks with Amazingly High Returns

      by Zacks Equity Research

      Net income ratio gives us the exact profitability level of a company and reflects the percentage of net income to total sales revenue.

        Intuitive Surgical (ISRG) Expects Strong Revenues in Q4

        by Zacks Equity Research

        Intuitive Surgical, Inc. (ISRG) announced that it expects fourth-quarter 2016 revenues of approximately $757 million.

          Fluidigm: Q4 Preliminary Results Fail to Cheer Investors

          by Zacks Equity Research

          The market is not really happy with South San Francisco, CA-based Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter and full-year 2016.

            Ecolab (ECL) Acquires Abednego Environmental, Shares Gain

            by Zacks Equity Research

            In a bid to strengthen its water solution line of offerings, St. Paul, MN-based Ecolab Inc. (ECL) announced the acquisition of Abednego Environmental Services.

              Can the Rally in Glaukos (GKOS) Shares Continue?

              by Zacks Equity Research

              Glaukos Corporation (GKOS) has been on the move lately as the stock has risen by 12.1% in the past four weeks, and it is currently trading well above its 20-Day SMA.

                DexCom Looking Forward to Strong Revenues in Q4 and 2016

                by Zacks Equity Research

                DexCom, Inc. (DXCM), a renowned medical device company, reported that it expects preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended Dec 31, 2016.

                  Integra LifeSciences at 52-Week High on Deals, View Update

                  by Zacks Equity Research

                  Shares of Integra LifeSciences Holdings Corporation (IART), a global leader in medical technology, scaled a new 52-week high of $45.50 on Jan 10, closing a tad lower at $44.90.

                    Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS

                    by Zacks Equity Research

                    Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.

                      Glaukos (GKOS) Catches Eye: Stock Adds 5.6% in Session

                      by Zacks Equity Research

                      Glaukos Corporation (GKOS) moved big last session, as its shares jumped almost 6% on the day.

                        4 Med Instrument Stocks for Q3 Earnings amid Election Chaos

                        by Zacks Equity Research

                        The medical device sector is positioned for impressive growth in the near term.

                          Brian Bolan headshot

                          5 Great Growth Stocks To Buy Now

                          by Brian Bolan

                          Revenue growth is the single biggest factor in selecting an aggressive growth stock.